COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,312 Articles (22,772 medRxiv, 8,540 bioRxiv)

Most recent first Previous |  Page 892: Articles 8911-8920  | Next

Differential Activity of Repurposed Drugs as Receptor Binding Domain Antagonists for Omicron and Native Strains of SarsCov2
Meher, K., K, S., Reddy, A., Kadiyala, G., Iyer, S., Vangala, S., Chandran, S., Saxena, U.
10.1101/2022.03.09.483630 — Posted: 2022-03-09
Selection of optimum formulation of RBD-based protein sub-unit covid19 vaccine (Corbevax) based on safety and immunogenicity in an open-label, randomized Phase-1 and 2 clinical studies
Thuluva, S., Paradkar, V., Turaga, K., Gunneri, S., Yerroju, V., Mogulla, R., Kyasani, M., Manoharan, S., Medigeshi, G. R., Singh, J., Shaman, H., Singh, C., Rao A, V.
10.1101/2022.03.08.22271822 — Posted: 2022-03-09
Culture and identification of a Deltamicron SARS-CoV-2 in a three cases cluster in southern France
Colson, P., Fournier, P.-E., Delerce, J., Million, M., Bedotto, M., Houhamdi, L., Yahi, N., Bayette, J., LEVASSEUR, A., Fantini, J., Raoult, D., LA SCOLA, B.
10.1101/2022.03.03.22271812 — Posted: 2022-03-08
Extensive neutralization against SARS-CoV-2 variants elicited by Omicron-specific subunit vaccine booster
Peng, P., Feng, C., Hu, J., He, C.-l., Deng, H., Fan, Q., Tang, G., Jiang, M., Hu, F., Li, F., Wang, K., Tang, N., Tang, X., Huang, A.
10.1101/2022.03.07.483373 — Posted: 2022-03-08
Hetero-bivalent Nanobodies Provide Broad-spectrum Protection against SARS-CoV-2 Variants of Concern including Omicron
Jin, T., Ma, H., Zhang, X., Zheng, P., Dube, P. H., Zeng, W., Chen, S., Yang, Y., Wu, Y., Zhou, J., Hu, X., Xiang, Y., Zhang, H., Chiu, S.
10.1101/2022.03.08.483381 — Posted: 2022-03-08
Defining factors that influence vaccine-induced, cross-variant neutralizing antibodies for SARS-CoV-2 in Asians
Gu, Y., Shunmuganathan, B. D., Qian, X., Gupta, R., Tan, R. S. W., Kozma, M., Purushotorman, K., Murali, T. M., Tan, N. Y. J., Preiser, P. R., Lescar, J., Nasir, H., Somani, J., Tambyah, P. A., SCOPE Cohort Study Group, , Smith, K. G. C., Renia, L., Ng, L. F. P., Lye, D. C., Young, B. E., MacAry, P. A.
10.1101/2022.03.06.22271809 — Posted: 2022-03-08
13 cis retinoic acid improved the outcomes of COVID-19 patients. A randomized clinical trial
Elkazzaz, M. R., Esam-Eldin Abo-Amer, Y., Ahmed, A., Hayadar, T.
10.1101/2022.03.05.22271959 — Posted: 2022-03-08
DIAGNOSTIC ACCURACY OF NON-INVASIVE DETECTION OF SARS-COV-2 INFECTION BY CANINE OLFACTION
GRANDJEAN, D., Elie, C., Gallet, C., Julien, C., Roger, V., Desquilbet, l., Alvergnat, G., Delarue, S., Gabassi, A., Minier, M., Choupeaux, L., Kerneis, S., Delaugere, C., Le Goff, J., Treluyer, J. M.
10.1101/2022.03.07.22271219 — Posted: 2022-03-08
Usefulness of real-time RT-PCR to understand the kinetics of SARS-CoV-2 in blood: a prospective study.
Zurita Cruz, N. D., Martin Ramirez, A., Rodriguez Serrano, D. A., Gonzalez Alvaro, I., Roy Vallejo, E., De la Camar, R., Fontan Garcia-Rodrigo, L., Cardenoso Domingo, L.
10.1101/2022.03.07.22271764 — Posted: 2022-03-08
Three separate spike antigen exposures by COVID-19 vaccination or SARS-CoV-2 infection elicit strong humoral immune responses in healthcare workers
Brehm, T. T., Ullrich, F., Thompson, M., Kuechen, J., Schwinge, D., Spier, A., Huber, S., Knobloch, J. K., Aepfelbacher, M., Addo, M. M., Lohse, A. W., Luetgehetmann, M., Schulze zur Wiesch, J.
10.1101/2022.03.06.22271718 — Posted: 2022-03-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).